NUCLIDIUM, a clinical-stage radiopharmaceutical company, today announced the appointment of Tony Rosenberg as Chairman of the Board, bringing over 40 years of transformative leadership and industry ...

The pan-European STOXX 600 was up 0.5% as of 0920 GMT, after touching a three-month low on Tuesday amid an investor rush to ...

First-in-class steroid-toxicity outcome assessments licensed by argenx to support development of novel steroid-sparing ...

Halozyme's strategic acquisition of Evotec and innovative ENHANZE technology present growth opportunities. Click here for a ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced the ...

DelveInsight's 'Systemic Lupus Erythematosus Pipeline Insight 2024' report provides comprehensive global coverage of pipeline ...

Collaboration to leverage Steritas’ STOX Suite in developing innovative treatments for autoimmune diseases.

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at ...

A partial list of companies that export to the U.S. from Bank of America as President-elect Donald Trump looks to impose ...

In a report released today, Joon Lee from Truist Financial assigned a Buy rating to Argenx Se (ARGX – Research Report). The company’s shares closed last Friday at $564.23. Don't Miss our Black Friday ...

SE (NASDAQ:ARGX – Get Free Report)’s stock price gapped down before the market opened on Friday . The stock had previously closed at $595.04, but opened at $572.41. argenx shares last traded at ...

Atria Investments Inc lessened its holdings in shares of argenx SE (NASDAQ:ARGX – Free Report) by 1.0% in the third quarter, ...